UBS Group’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,802
| Closed | -$56.8K | – | 9932 |
|
|
2022
Q4 | $56.8K | Buy |
2,802
+1,356
| +94% | +$27.5K | ﹤0.01% | 5502 |
|
|
2022
Q3 | $16K | Buy |
1,446
+266
| +23% | +$2.94K | ﹤0.01% | 6657 |
|
|
2022
Q2 | $14K | Buy |
1,180
+158
| +15% | +$1.88K | ﹤0.01% | 6419 |
|
|
2022
Q1 | $22K | Buy |
1,022
+717
| +235% | +$15.4K | ﹤0.01% | 6330 |
|
|
2021
Q4 | $10K | Sell |
305
-133
| -30% | -$4.36K | ﹤0.01% | 7718 |
|
|
2021
Q3 | $11K | Sell |
438
-757
| -63% | -$19K | ﹤0.01% | 6788 |
|
|
2021
Q2 | $16K | Buy |
+1,195
| New | +$16K | ﹤0.01% | 6507 |
|
|
2021
Q1 | – | Sell |
-1,943
| Closed | -$16K | – | 8407 |
|
|
2020
Q4 | $16K | Buy |
1,943
+221
| +13% | +$1.82K | ﹤0.01% | 6115 |
|
|
2020
Q3 | $13K | Buy |
+1,722
| New | +$13K | ﹤0.01% | 5787 |
|
|
2020
Q1 | – | Sell |
-964
| Closed | -$14K | – | 7347 |
|
|
2019
Q4 | $14K | Buy |
+964
| New | +$14K | ﹤0.01% | 6040 |
|
|
2019
Q2 | – | Sell |
-2,235
| Closed | -$30K | – | 7232 |
|
|
2019
Q1 | $30K | Buy |
2,235
+689
| +45% | +$9.25K | ﹤0.01% | 5130 |
|
|
2018
Q4 | $22K | Sell |
1,546
-2,069
| -57% | -$29.4K | ﹤0.01% | 5799 |
|
|
2018
Q3 | $65K | Buy |
3,615
+1,631
| +82% | +$29.3K | ﹤0.01% | 5080 |
|
|
2018
Q2 | $28K | Sell |
1,984
-1,916
| -49% | -$27K | ﹤0.01% | 5538 |
|
|
2018
Q1 | $75K | Buy |
3,900
+2,604
| +201% | +$50.1K | ﹤0.01% | 4586 |
|
|
2017
Q4 | $29K | Buy |
1,296
+1,078
| +494% | +$24.1K | ﹤0.01% | 5305 |
|
|
2017
Q3 | $8K | Buy |
+218
| New | +$8K | ﹤0.01% | 6101 |
|